Quantification of walking mobility in neurological disorders

QJM: An International Journal of Medicine

Volumn 97, Issue 8, 2004, Pages 463-475

  Pearson, O R ^a   Busse, M E ^a   Van Deursen, R W M ^a   Wiles, C M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELEROMETER; AMBULATORY MONITORING; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DAILY LIFE ACTIVITY; ENERGY EXPENDITURE; EXERCISE TEST; FUNCTIONAL ASSESSMENT; HOME MONITORING; HUMAN; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PARKINSON DISEASE; PATIENT MOBILITY; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RATING SCALE; RELIABILITY; REVIEW; SELF REPORT; STANDARDIZATION; TASK PERFORMANCE; TIME SERIES ANALYSIS; VALIDATION PROCESS; VIDEORECORDING; WALKING SPEED;

EID: 4344574329     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch084     Document Type: Review

References (70)

1. Chiou, II, Burnett CN. Values of activities of daily living. A survey of stroke patients and their home therapists. Phys Ther 1985; 65:901-6.
2. WHO. International Classification of Functioning, Disability and Health: ICF. Geneva, World Health Organization, 2001.
3. Ferrucci L, Guralnik JM, Buchner D, Kasper J, Lamb SE, Simonsick EM, et al. Departures from linearity in the relationship between measures of muscular strength and physical performance of the lower extremities: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 1997; 52:M275-85.
4. ABN. Guidelines for the use of beta interferons and glatiramer acetate in multiple sclerosis. Association of British Neurologists, January 2001.
5. Bussmann JB, Stam HJ. Techniques for measurement and assessment of mobility in rehabilitation: a theoretical approach. Clin Rehabil 1998; 12:455-64.
6. Hobart JC, Lamping DL, Thompson AJ. Evaluating neurological outcome measures: the bare essentials. J Neurol Neurosurg Psychiatry 1996; 60:127-30.
7. Collen FM, Wade DT, Bradshaw CM. Mobility after stroke: reliability of measures of impairment and disability. Int Disabil Stud 1990; 12:6-9.
8. Watson MJ. Refining the ten-metre walking test for use with neurologically impaired people. Physiotherapy 2002; 88:386-97.
9. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, et al. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983; 308:173-80.
10. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5:244-50.
11. Wade DT. Measurement in Neurological Rehabilitation. Oxford, Oxford University Press, 1992.
12. Bohannon RW, Andrews AW, Thomas MW. Walking speed: reference values and correlates for older adults. J Orthop Sports Phys Ther 1996; 24:86-90.
13. Green J, Forster A, Young J. Reliability of gait speed measured by a timed walking test in patients one year after stroke. Clin Rehabil 2002; 16:306-14.
14. Vaney C, Blaurock H, Gattlen B, Meisels C. Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed. Clin Rehabil 1996; 10:216-26.
15. Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD. Quantitative functional measures in MS: what is a reliable change? Neurology 2002; 58:1294-6.
16. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J Clin Res Ed 1982; 284:1607-8.
17. Rossier P, Wade DT. Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. Arch Phys Med Rehabil 2001; 82:9-13.
18. Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003; 60:1119-24.
19. Lord SR, Menz HB. Physiologic, psychologic, and health predictors of 6-minute walk performance in older people. Arch Phys Med Rehab 2002; 83:907-11.
20. Van Deursen R, Button K, Lawthom C. Measurement of spatial and temporal gait parameters using a digital camcorder. Gait Posture 2001; 14:128.
21. Lord SE, Halligan PW, Wade DT. Visual gait analysis: the development of a clinical assessment and scale. Clin Rehabil 1998; 12:107-19.
22. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70:174-9.
23. Wiles CM, Newcombe RG, Fuller KJ, Jones A, Price M. Use of videotape to assess mobility in a controlled randomized crossover trial of physiotherapy in chronic multiple sclerosis. Clin Rehabil 2003; 17:256-63.
24. Ijzerman MJ, Nene AV. Feasibility of the physiological cost index as an outcome measure for the assessment of energy expenditure during walking. Arch Phys Med Rehabil 2002; 83:1777-82.
25. Waters RL, Mulroy S. The energy expenditure of normal and pathologic gait. Gait Posture 1999; 9:207-31.
26. Perry J. Gait Analysis: normal and pathological function. Thorofare NJ, Slack Inc, 1992.
27. Hobart J. Measuring disease impact in disabling neurological conditions: are patients' perspectives and scientific rigor compatible? Curr Opin Neurol 2002; 15:721-4.
28. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead mobility index: A further development of the Rivermead motor assessment. Int Disabil Studies 1991; 13:50-4.
29. Sharrack B, Hughes RA, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999; 122:141-59.
30. Schwid SR, Goodman AD, Mattson DH, Mihai C, Donohoe KM, Petrie MD, et al. The measurement of ambulatory impairment in multiple sclerosis. Neurology 1997; 49:1419-24.
31. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
32. Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis: a critique. Neurology 1988; 38:1793-8.
33. Goodkin DE. EDSS reliability. Neurology 1991; 41:332.
34. Albrecht H, Wotzel C, Erasmus LP, Kleinpeter M, Konig N, Pollmann W. Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter. Mult Scler 2001; 7:105-9.
35. Sharrack B, Hughes RA. Reliability of distance estimation by doctors and patients: cross sectional study. Br Med J 1997; 315:1652-4.
36. Giantomaso T, Makowsky L, Ashworth NL, Sankaran R. The validity of patient and physician estimates of walking distance. Clin Rehabil 2003; 17:394-401.
37. Sharrack B, Hughes RA. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999; 5:223-33.
38. Sharrack B, Dunn G, Soudain S, Wiles CM, Hawkins S, Young C, et al. The United Kingdom Neurology Disability Scale (UNDS): a novel outcome measure for use in multiple sclerosis clinical trials. Personal communication.
39. Ware JE. Measuring patients' views: the optimum outcome measure. Br Med J 1993; 306:1429-30.
40. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124:962-73.
41. McGuigan C, Hutchinson M. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiat 2004; 75:266-9.
42. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60:31-6.
43. Kenealy P, Beaumont G, Lintern T, Murrell R. Autobiographical memory, depression and quality of life in multiple sclerosis. J Clin Exp Neuropsychol 2000; 22:125-31.
44. Richardson MT, Leon AS, Jacobs DR, Jr., Ainsworth BE, Serfass R. Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. J Clin Epidemiol 1994; 47:271-81.
45. Richardson MT, Ainsworth BE, Jacobs DR, Leon AS. Validation of the Stanford 7-day recall to assess habitual physical activity. Ann Epidemiol 2001; 11:145-53.
46. Bassett DR, Jr., Cureton AL, Ainsworth BE. Measurement of daily walking distance-questionnaire versus pedometer. Med Sci Sports Exerc 2000; 32:1018-23.
47. Mayo E. The human problems of an industrial civilization. New York, MacMillan, 1933.
48. Ng AV, Kent-Braun JA. Quantitation of lower physical activity in persons with multiple sclerosis. Med Sci Sports Exerc 1997; 29:517-23.
49. LaPorte R, Montoye H, Caspersen C. Assessment of physical activity in epidemiologic research: problems and prospects. Public Health Rep 1985; 100:131-46.
50. Bassett DR, Jr., Ainsworth BE, Leggett SR, Mathien CA, Main JA, Hunter DC, et al. Accuracy of five electronic pedometers for measuring distance walked. Med Sci Sports Exerc 1996; 28:1071-7.
51. Coleman KL, Smith DG, Boone DA, Joseph AW, del Aguila MA. Step activity monitor: long-term, continuous recording of ambulatory function. J Rehabil Res Dev 1999; 36:8-18.
52. Shepherd EF, Toloza E, McClung CD, Schmalzried TP. Step activity monitor: increased accuracy in quantifying ambulatory activity. J Orthopaed Res 1999; 17:703-8.
53. Macko RF, Haeuber E, Shaughnessy M, Coleman KL, Boone DA, Smith GV, et al. Microprocessor-based ambulatory activity monitoring in stroke patients. Med Sci Sports Exerc 2002; 34:394-9.
54. Brandes M, Rosenbaum D. Correlations between the step activity monitor and the DynaPort ADL-monitor. Clin Biomech 2004; 19:91-4.
55. Pearson OR, Busse ME, van Deursen R, Wiles CM. Quantification of walking mobility in Multiple Sclerosis (MS) using an ambulatory activity monitor - a pilot study. J Neurol Neurosurg Psychiat 2003; 74:1450.
56. Busse ME, Pearson OR, van Deursen RWM, Wiles CM. Activity indices for measuring mobility in neurologically impaired patients. J Neurol Neurosurg Psychiat 2004; 75:884-8.
57. Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr. Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc 2002; 34:1376-81.
58. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S MC, Calne DB, Goldstein M, ed. Recent Developments in Parkinson's Disease. Florham Park NJ, Macmillan Health Care Information, 1987; 153-63, 293-304.
59. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. In: Eisenberg MGR, ed. Advances in clinical rehabilitation. New York, Springer Verlag, 1987:6-18.
60. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14:61-5.
61. Nouri FM, Lincoln NB. An extended activities of daily living in scale for stroke patients. Clin Rehabil 1987; 1:301-5.
62. Ware JEJ, Snow KK, Kosinski M. SF-36 health survey manual and interpretation guide. Boston, Nimrod Press, 1993.
63. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60:31-6.
64. Francis DA, Bain P, Swan AV, Hughes RA. An assessment of disability rating scales used in multiple sclerosis. Arch Neurol 1991; 48:299-301.
65. Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000; 123:1027-40.
66. Rossier P, Wade DT. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity. Clin Rehabil 2002; 16:75-95.
67. Hoogervorst EL, van Winsen LM, Eikelenboom MJ, Kalkers NF, Uitdehaag BM, Polman CH. Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Neurology 2001; 56:934-7.
68. Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I, et al. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial. Movement Disorders 2002; 17:758-63.
69. Hobart JC, Lamping DL, Freeman JA, Langdon DW, McLellan DL, Greenwood RJ, et al. Evidence-based measurement: which disability scale for neurologic rehabilitation? Neurology 2001; 57:639-44.
70. Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A. The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry 2001; 71:363-70.